Clorox (NYSE:CLX) Updates FY 2027 Earnings Guidance

Clorox (NYSE:CLX) issued an update on its FY 2027 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.700-6.000 for the period, compared to the consensus EPS estimate of 6.230. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.5 billion.

Clorox Stock Up 2.9%

CLX opened at $98.25 on Tuesday. The stock’s 50 day moving average price is $95.57 and its 200 day moving average price is $103.57. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock has a market cap of $11.88 billion, a P/E ratio of 15.95 and a beta of 0.54. Clorox has a 12 month low of $84.70 and a 12 month high of $128.90.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.91 billion. During the same quarter in the prior year, the business posted $2.87 earnings per share. The company’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, research analysts predict that Clorox will post 5.52 earnings per share for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.1%. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. Clorox’s payout ratio is 80.52%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. Royal Bank Of Canada decreased their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. UBS Group boosted their price objective on Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Finally, Morgan Stanley lowered their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Twelve analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $101.00.

Trending Headlines about Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Quarterly results topped estimates. Clorox reported fiscal fourth-quarter EPS of $1.66, slightly above the $1.64 consensus, while revenue of $1.95 billion exceeded expectations of $1.91 billion. Clorox Q4 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Fiscal 2027 sales outlook is encouraging. Management expects revenue to grow approximately 13% to 14%, or reach $7.6 billion to $7.7 billion, above the roughly $7.5 billion analyst consensus. The company cited improving demand in health and wellness products and international markets. Clorox forecasts upbeat annual sales as demand improves
• Positive Sentiment: Cash-generation target and dividend support investor sentiment. Clorox outlined a fiscal 2027 free-cash-flow target of 11% to 13% of sales and declared a quarterly dividend of $1.25 per share, a modest increase from $1.24. Clorox outlines inflation and free cash flow target

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Caitlin John LLC boosted its stake in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the period. Darwin Wealth Management LLC purchased a new stake in shares of Clorox in the second quarter valued at $29,000. MUFG Securities EMEA plc acquired a new stake in shares of Clorox in the second quarter worth $44,000. DV Equities LLC acquired a new stake in shares of Clorox in the fourth quarter worth $46,000. Finally, Golden State Wealth Management LLC grew its holdings in shares of Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.